GVAX Pancreas Vaccine (With CY) in Combination With Nivolumab and SBRT for Patients With Borderline Resectable Pancreatic Cancer
Clinical trial NCT03161379 · COMPLETED
Trial details
- NCT number
- NCT03161379
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-02
- Primary completion
- 2024-02-20
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.